Thermo Fisher Scientific (TMO) Misses Q2 EPS by 28c; lowers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts TMO Hot Sheet
Price: $703.91 +0.80%
Financial Fact:
Cost of product revenues: 2.02B
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Cost of product revenues: 2.02B
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Thermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $5.15, $0.28 worse than the analyst estimate of $5.43. Revenue for the quarter came in at $10.69 billion versus the consensus estimate of $10.99 billion.
GUIDANCE:
Thermo Fisher Scientific sees FY2023 EPS of $22.28-$22.72, versus the consensus of $23.55. Thermo Fisher Scientific sees FY2023 revenue of $43.4-44 billion, versus the consensus of $45.21 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- SharkNinja (SN) Tops Q3 EPS by 74c; Offers Guidance
- Marriott Vacations Worldwide (VAC) Tops Q3 EPS by 7c; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
